Eli Lilly and Company (LLY)

NYSE - NYSE Delayed Price. Currency in USD

Visitors trend2W10W9M

337.65

+3.05

(+0.91%)

At close: 04:03PM EDT

337.65

0.00

(0.00%)

After hours:

04:21PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Price Crosses Moving Average

View all chart patterns

Performance Outlook

Previous Close	334.60
Open	335.80
Bid	0.00 x 1000
Ask	0.00 x 1100
Day's Range	334.71 - 338.83
52 Week Range	276.83 - 375.25
Volume	2,359,920
Avg. Volume	3,161,921

Market Cap	321.56B
Beta (5Y Monthly)	0.35
PE Ratio (TTM)	49.01
EPS (TTM)	6.89
Earnings Date	Apr 27, 2023
Forward Dividend & Yield	4.52 (1.35%)
Ex-Dividend Date	Feb 14, 2023
1y Target Est	380.75

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Near Fair Value

19% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for LLY

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Eli Lilly and Company
Daily – Vickers Top Buyers & Sellers for 03/28/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Rating
Fair Value
Economic Moat
10 hours agoArgus Research

All

Motley Fool
Is Eli Lilly or Bristol Myers Squibb the Better Value Stock to Buy Right Now?
While growth stocks boomed in the era of easy money, value stocks have returned to form as the market's top performers in the current high interest rate environment. Now, value comes in many forms, such as a highly dependable dividend, an economically insensitive revenue stream, the quality of a company's management team, long-term growth drivers, and/or an attractive valuation. In the present risk-averse market, the most highly prized aspects of value stocks appear to be the dependability of a company's dividend, along with its ability to generate strong free cash flows regardless of the state of the broader economy.
Investor's Business Daily
Novartis Surges As It Goes After Eli Lilly's Second Biggest Moneymaker
Novartis stock surged Monday after the company's treatment reduced the risk of relapse in patients with early-stage breast cancer.
- Novartis (NVS) Kisqali Positive for Early Breast Cancer
  Zacks
- Novartis shares jump on breast cancer drug trials success
  Fox Business
Zacks
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
- Want Better Returns? Don't Ignore These 2 Computer and Technology Stocks Set to Beat Earnings
  Zacks
- How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
  Zacks